Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

Stocks skip higher ahead of U.S. jobs data

Published 07/01/2020, 08:04 PM
Updated 07/02/2020, 05:25 AM
© Reuters. An SGX sign is pictured at Singapore Stock Exchange

By Marc Jones

LONDON (Reuters) - World stocks rose for a fourth straight day on Thursday as encouraging coronavirus vaccine trials kept investors' spirits up ahead of what was expected to be a record rebound in U.S. jobs figures later.

Economists polled by Reuters expect a bumper 3 million U.S. jobs to have been added in June on top of the 2.5 million created in May, and some generally reassuring data from both Asia and Europe this week.

Despite the ongoing rise in global virus cases, Asian equity markets saw their biggest daily rise in over two weeks overnight, aided by news that a vaccine being trialled by Pfizer (NYSE:PFE) and Germany's BioNTech had been well tolerated in early-stage human tests.

Europe made a strong start, with banking, travel and carmaker stocks driving 1-2% gains for its main bourses, and the euro helped back up towards $1.13 by another drop in the dollar.

"The big thing today is the U.S. non-farm payrolls... but by and large risk has been bid and the dollar has been weakening," said RBC FX strategist Alvin Tan.

"What has really helped sentiment (in the last 24 hours) has been some of the preliminary results on a vaccine".

A vaccine for COVID-19, which has now killed more than half a million people globally and sent the world economy into deep recession, has been long anticipated.

In a sign the positive sentiment will extend, E-minis for S&P500 rose 0.8%, while bond markets were also favouring risk over safety.

The 10-year Germany Bund yield broke above -0.4% for the first time in a week in its biggest daily jump in a month after improved euro zone manufacturing data the previous day, while Portugal's borrowing costs hit a 3-month low.

All major Asian indexes had been upbeat. Japan's Nikkei rose only fractionally, but China's blue-chip index added 2% and Hong Kong's Hang Seng jumped 2.8% as investors brushed off concerns over sweeping new security laws introduced by Beijing.


Attention was quickly turning to the U.S. employment figures later that will feed debate on whether the world's largest economy can sustain its fragile recovery in the face of rising COVID-19 cases in some key parts of the country.

"A better-than-expected outcome could go some way to settling the near-term debate that the U.S. labor market will heal relatively quickly and justify new highs in U.S. equities," said Stephen Innes, strategist at AxiCorp.

In commodities, the most-traded August copper contract on the Shanghai Futures Exchange touched 49,570 yuan ($7,016.28) a tonne, its highest of the year.

Top copper consumer China posted better-than-expected manufacturing data in June, while U.S. manufacturing activity rebounded and the factory sector in Germany contracted at a slower pace.

In Chile, where the number of COVID-19 cases have been climbing, miner BHP said it would begin to slow production at its small Cerro Colorado copper mine.

Oil prices climbed and gold eased as encouraging macro data prompted investors to take on more risk.

Brent crude climbed 30 cents to $42.37 a barrel. U.S. crude rose 35 cents to $40.17 a barrel. U.S. gold futures were 0.21% lower, at $1,776.20.

© Reuters. The German share price index DAX graph is pictured at the stock exchange in Frankfurt

The dollar was largely unchanged against the Japanese yen at 107.45. The euro was higher at $1.1293, sterling rose to $1.2520 and the risk-sensitive Australian and New Zealand dollars were 0.3% and 0.5% stronger respectively.

Latest comments

what about NASDAQ today?
Count me out on the vaccine tested less than 3 years... side effects, you have to make sure the cure isn't worse than the disease.
  who's the one drinkin' koolaid!?!?!
If u buy chinese stocks (any chinese company), u support china. We all try to keep politic out of our investments but we cant look away n keep invest in china anymore.
I don't give a ****** Am investing to make money
China don't need you, you need chines stocks for your own profit.
Profit....that’s all...chinese or antarctica same****
"Equity investors shrugged off concerns"...geez....US should get used with the Idea that HK is China....
...and why would Asia care about US payrolls..???
u know is obvious that the media is paid to manipulate and to draw attention all the time on US internal political are related the Asian stocks to US payrolls??...
US is the top importer of Asian goods
Vaccine and recovery hopes, coronavirus matter where to market moves, journalists are playing 2 cards...
just simpletons at Reuters and the selection of news by interns at
They are just like the Moving Averages.
What vaccine? Stop the fake news.
lazy "financial news" has just replaced trade war headlines everyday with COVID-1984 nonsense
covid 1984 - ha, that was good
Why asiN markets dependent on us payroll, you guys lost brains 😂
i heard about vaccine maybe more than 50times this weeks..and its still hope
not a single word by investing on China's fake gold. this is not journalism.
4%+ of their total supply. I wonder what percentage of the world’s gold reserves aren’t even gold...
Can hardly wait for Reuters US doom and gloom report.
What vaccine? We have heard this news more than 17times... Still no advancement.
Rinse and repeat
Title translation... “China stocks are going up.... but I think they should be going down”
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.